Michele Andrasik

Dr Andrasik, a middle-aged black woman with shoulder-length curly hair

Michele Andrasik, PhD

Affiliate Associate Professor
Email: mandrasik@fredhutch.org
Expertise: Sustainable Communities, Community-engaged Research, Health Equity, Risk Assessment

About

Michele Andrasik is a clinical health psychologist. She is the Director of Social and Behavioral Sciences and Community Engagement for the Fred Hutchinson-based HIV Vaccine Trials Network (HVTN), Senior Staff Scientist in the Fred Hutchinson Vaccine and Infectious Disease Division and an Affiliate Assistant Professor in the Departments of Global Health and Environmental and Occupational Health Sciences at the University of Washington. Dr. Andrasik has worked in HIV prevention for over 25 years. Her focus has been on social and structural factors implicated in health inequities and stigma and discrimination experienced by communities with devalued identities (racial, ethnic, sexual and gender minorities).

An expert in Community-Based Participatory Research (CBPR) and qualitative methods research, Dr. Andrasik has led a robust Social and Behavioral Sciences research agenda for the HVTN for almost a decade. She has extensive experience facilitating training on implicit bias, stigma, microaggressions and trauma to researchers, community-based organization staff and health departments.

Education

  • BA, Psychology, New York University, New York, NY
  • EdM, Psychological Counseling, Columbia University, Teachers College
  • MA, Health Education, Columbia University, Teachers College, NY, NY
  • MS, Psychology, University of Miami, Coral Gables, FL
  • Predoctoral Psychology Internship, Seattle Veterans Affairs Medical Center, Seattle, WA
  • PhD, Clinical Health Psychology, University of Miami, Coral Gables, FL

Affiliations

HVTN - Director of Social & Behavioral Sciences and Community Engagement

Mentorship

DEOHS Students Mentored

Getting Pediatric Care in Gentrifying King County
Katherine Ly | MPH | 2020 | View

Media Mentions

Early coronavirus drug trials tested vaccines mostly on white people; next phase aims for diversity
August 6, 2020 | CNBC | Featured: Michele Andrasik | View